| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
LENZ
LENZ Therapeutics
|
Oct 30, 2026 | HOLD |
Buy
+470.0% avg upside
17 analysts
|
$4.00
31.05% Upside
|
+35.4% | · |
|
MRK
Merck & Company
|
Oct 30, 2026 | BUY |
Strong Buy
-3.5% avg upside
44 analysts
|
$165.00
10.28% Upside
|
-1.2% | · |
|
LLY
Eli Lilly & Co
|
Oct 29, 2026 | BUY |
Strong Buy
-16.7% avg upside
50 analysts
|
$1497.00
5.53% Upside
|
+3.9% | · |
|
BMY
Bristol-Myers Squibb
|
Oct 29, 2026 | BUY |
Buy
-2.2% avg upside
42 analysts
|
$67.00
7.31% Upside
|
+1.4% | · |
|
ABBV
AbbVie
|
Oct 22, 2026 | BUY |
Strong Buy
-14.5% avg upside
47 analysts
|
$305.00
3.48% Upside
|
+3.5% | · |
|
LQDA
Liquidia Technologies
|
Oct 14, 2026 | HOLD |
Strong Buy
+0.7% avg upside
15 analysts
|
$42.00
6.75% Downside
|
+69.2% | · |
|
JNJ
Johnson & Johnson
|
Oct 14, 2026 | HOLD |
Strong Buy
-9.1% avg upside
40 analysts
|
$275.00
0.68% Upside
|
+11.7% | · |
|
HRMY
Harmony Biosciences Holdings
|
Oct 12, 2026 | SELL |
Strong Buy
+27.3% avg upside
14 analysts
|
$30.00
22.68% Downside
|
+11.7% | · |
|
XENE
Xenon
|
Oct 12, 2026 | BUY |
Strong Buy
+53.0% avg upside
28 analysts
|
$77.00
105.85% Upside
|
+13.0% | · |
|
ARWR
Arrowhead Pharmaceuticals
|
Oct 12, 2026 | BUY |
Strong Buy
+26.6% avg upside
29 analysts
|
$100.00
66.90% Upside
|
-18.7% | · |
|
VTRS
Viatris
|
Oct 12, 2026 | SELL |
Buy
+25.5% avg upside
22 analysts
|
$16.00
15.85% Downside
|
-18.7% | · |
|
APMD
Apnimed, Inc.
|
Oct 12, 2026 | BUY |
Strong Buy
+206.9% avg upside
4 analysts
|
$41.00
150.02% Upside
|
-9.2% | · |
|
GUTS
Fractyl Health, Inc.
|
Oct 12, 2026 | BUY |
Strong Buy
+1326.9% avg upside
7 analysts
|
$24.00
2357.77% Upside
|
-79.6% | · |
|
MLYS
Mineralys Therapeutics, Inc.
|
Oct 12, 2026 | BUY |
Strong Buy
+150.9% avg upside
12 analysts
|
$49.00
169.59% Upside
|
-31.0% | · |
|
OCS
Oculis Holding
|
Oct 12, 2026 | BUY |
Strong Buy
+367.7% avg upside
11 analysts
|
$32.00
287.45% Upside
|
-3.0% | · |
|
ALVO
Alvotech
|
Oct 12, 2026 | BUY |
Strong Buy
+87.4% avg upside
7 analysts
|
$7.00
50.47% Upside
|
-23.4% | · |
|
TARS
Tarsus Pharmaceuticals
|
Oct 12, 2026 | BUY |
Strong Buy
+9.9% avg upside
17 analysts
|
$84.00
12.29% Upside
|
+7.9% | · |
|
BMRN
BioMarin Pharmaceutical
|
Oct 09, 2026 | BUY |
Strong Buy
+63.6% avg upside
52 analysts
|
$86.00
46.99% Upside
|
+4.4% | · |
|
IL:TEVA
Teva
|
Oct 09, 2026 | BUY |
Strong Buy
+18.1% avg upside
8 analysts
|
$13521.63
5.67% Upside
|
+7.5% | · |
|
RPRX
Royalty Pharma
|
Oct 09, 2026 | BUY |
Strong Buy
-12.2% avg upside
15 analysts
|
$63.00
6.29% Downside
|
+21.8% | · |
|
AXSM
Axsome Therapeutics
|
Oct 09, 2026 | BUY |
Strong Buy
+63.9% avg upside
30 analysts
|
$276.00
91.17% Upside
|
-15.8% | · |
|
UTHR
United Therapeutics
|
Oct 09, 2026 | HOLD |
Buy
-22.7% avg upside
27 analysts
|
$559.00
6.56% Downside
|
+7.6% | · |
|
PFE
Pfizer
|
Oct 09, 2026 | HOLD |
Buy
+9.2% avg upside
46 analysts
|
$29.00
4.94% Downside
|
+5.2% | · |
|
JAZZ
Jazz Pharmaceuticals
|
Oct 09, 2026 | BUY |
Strong Buy
+16.2% avg upside
36 analysts
|
$313.00
44.87% Upside
|
+10.6% | · |
|
IONS
Ionis Pharmaceuticals
|
Oct 09, 2026 | BUY |
Strong Buy
+74.1% avg upside
44 analysts
|
$91.00
109.09% Upside
|
-31.5% | · |
|
EXEL
Exelixis
|
Oct 09, 2026 | SELL |
Buy
-34.0% avg upside
34 analysts
|
$41.00
40.96% Downside
|
-15.3% | · |
|
ALKS
Alkermes
|
Oct 09, 2026 | SELL |
Buy
-3.4% avg upside
34 analysts
|
$38.00
16.14% Downside
|
-14.0% | · |
|
PCVX
Vaxcyte
|
Oct 05, 2026 | BUY |
Strong Buy
+77.8% avg upside
15 analysts
|
$146.00
135.34% Upside
|
-14.2% | · |
|
AMLX
Amylyx Pharmaceuticals Inc
|
Aug 18, 2026 | BUY |
Strong Buy
+31.6% avg upside
14 analysts
|
$39.00
35.21% Upside
|
-13.7% | · |
|
AMPH
Amphastar Pharmaceuticals
|
Aug 07, 2026 | SELL |
Hold
-3.5% avg upside
11 analysts
|
$20.00
27.76% Downside
|
-38.9% | · |
|
IMVT
Immunovant
|
May 21, 2026 | BUY |
Strong Buy
+38.4% avg upside
25 analysts
|
$43.00
47.40% Upside
|
+0.8% | · |
|
TSE:BHC
Bausch Health Companies
|
Feb 18, 2026 | SELL |
Buy
+386.9% avg upside
30 analysts
|
$6.99
39.12% Downside
|
-35.8% | · |
|
OGN
Organon
|
Feb 13, 2026 | SELL |
Sell
+7.4% avg upside
9 analysts
|
— | -89.4% | · |
|
PROK
ProKidney
|
Jan 12, 2026 | SELL |
Buy
+393.1% avg upside
12 analysts
|
$1.00
22.76% Downside
|
+54.9% | · |
|
BHVN
Biohaven Ltd.
|
Nov 10, 2025 | HOLD |
Buy
+51.3% avg upside
25 analysts
|
$10.00
35.11% Downside
|
+94.0% | · |
|
NL:LKFT
Lakefront Biotherapeutics NV
|
Nov 07, 2025 | SELL |
Sell
+75.8% avg upside
17 analysts
|
— | -6.9% | · |
|
RLAY
Relay Therapeutics
|
Nov 06, 2025 | BUY |
Strong Buy
+22.4% avg upside
22 analysts
|
$15.00
18.21% Downside
|
+184.8% | · |
|
LKFT
Lakefront Biotherapeutics
|
Nov 06, 2025 | SELL |
Buy
+217.3% avg upside
25 analysts
|
$28.00
13.18% Downside
|
-7.2% | · |
|
LYRA
Lyra Therapeutics
|
May 23, 2024 | HOLD |
Hold
+12005.3% avg upside
7 analysts
|
— | · | · |
|
CHRS
Coherus Biosciences
|
Oct 30, 2023 | HOLD |
Buy
+1336.6% avg upside
19 analysts
|
— | -75.1% | · |
|
ALLO
Allogene Therapeutics
|
Sep 28, 2023 | HOLD |
Strong Buy
+1186.8% avg upside
28 analysts
|
— | -14.7% | · |
|
TVRD
Tvardi Therapeutics
|
Aug 09, 2023 | SELL |
Buy
+2090.0% avg upside
24 analysts
|
$3.50
341.40% Upside
|
· | · |
|
KYNB
Kyntra Bio
|
Aug 08, 2023 | SELL |
Buy
+615.8% avg upside
17 analysts
|
$2.00
56.28% Downside
|
+69.4% | · |
|
BYSI
Beyondspring
|
Jan 05, 2023 | SELL |
Buy
+1152.3% avg upside
8 analysts
|
$1.00
55.32% Upside
|
+49.7% | · |
|
VRCA
Verrica Pharmaceuticals
|
Jul 15, 2020 | HOLD |
Strong Buy
+411.2% avg upside
9 analysts
|
$10.00
198.49% Upside
|
+30.7% | · |
|
YARW
Yarrow Bioscience
|
Mar 11, 2020 | BUY |
Strong Buy
+38.5% avg upside
9 analysts
|
$32.00
60.81% Upside
|
· | · |
|
ALNY
Alnylam Pharma
|
Nov 13, 2019 | BUY |
Strong Buy
+76.3% avg upside
53 analysts
|
$110.00
33.36% Downside
|
+49.6% | · |
|
NBRVF
Nabriva Therapeutics
|
Aug 20, 2019 | BUY |
Buy
+13374900.0% avg upside
9 analysts
|
$6.00
5999900.09% Upside
|
· | · |
|
DE:MRK
Merck KGaA
|
Jun 28, 2019 | SELL |
Buy
-7.2% avg upside
34 analysts
|
— | -12.4% | · |
|
SPRO
Spero Therapeutics
|
Oct 16, 2018 | SELL |
Buy
+1102.8% avg upside
13 analysts
|
$9.00
749.09% Upside
|
-27.1% | · |
|
ARDX
Ardelyx
|
Nov 20, 2016 | BUY |
Strong Buy
+324.3% avg upside
21 analysts
|
$18.00
494.00% Upside
|
-63.6% | · |
|
HRTX
Heron Therapeutics
|
Nov 15, 2016 | BUY |
Strong Buy
+10208.0% avg upside
21 analysts
|
$34.00
12143.42% Upside
|
· | · |
|
PCRX
Pacira Pharmaceuticals
|
Nov 02, 2016 | HOLD |
Hold
+11.8% avg upside
23 analysts
|
$37.00
1.62% Upside
|
-0.9% | · |
|
PRGO
Perrigo Company
|
Aug 10, 2016 | HOLD |
Buy
+333.3% avg upside
20 analysts
|
$81.00
413.24% Upside
|
-10.0% | · |
|
AMRX
Amneal Pharmaceuticals
|
Aug 09, 2016 | HOLD |
Strong Buy
-10.1% avg upside
19 analysts
|
$24.00
11.55% Upside
|
· | · |
|
NVO
Novo Nordisk
|
Aug 08, 2016 | HOLD |
Hold
+188.3% avg upside
26 analysts
|
— | -10.1% | · |
|
IRWD
Ironwood Pharma
|
Aug 05, 2016 | HOLD |
Buy
+239.4% avg upside
23 analysts
|
$14.00
300.04% Upside
|
+15.6% | · |
|
NBIX
Neurocrine
|
Jul 13, 2016 | BUY |
Strong Buy
+27.3% avg upside
37 analysts
|
$70.00
52.12% Downside
|
+1.6% | · |
|
CARM
Carisma Therapeutics
|
Jan 19, 2016 | HOLD |
Buy
+584900.0% avg upside
11 analysts
|
— | · | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.